A phase III randomized trial of high‐dose CEOP + filgrastim versus standard‐dose CEOP in patients with non‐Hodgkin lymphoma: 10‐year follow‐up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial
Hertzberg, Mark, Matthews, Jane Palfrey, Stone, Janey Malka, Dubosq, Ming‐Celine, Grigg, Andrew, Ellis, David, Benson, Warwick, Browett, Peter, Horvath, Noemi, Januszewicz, Henry, Abdi, Ehtesham, Green, Michael, Bonaventura, Anthony, Marlton, Paula, Cannell, Paul, Wolf, Max
Published in American journal of hematology (01.05.2014)
Published in American journal of hematology (01.05.2014)
Get full text
Journal Article